Compare HALO & HUBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | HUBS |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 12.0B |
| IPO Year | 2001 | 2014 |
| Metric | HALO | HUBS |
|---|---|---|
| Price | $108.28 | $243.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 32 |
| Target Price | $78.64 | ★ $435.19 |
| AVG Volume (30 Days) | ★ 2.3M | 1.9M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 855.56 |
| EPS | ★ 3.11 | 1.47 |
| Revenue | $151,862,000.00 | ★ $375,612,000.00 |
| Revenue This Year | $28.24 | $20.46 |
| Revenue Next Year | $12.56 | $16.01 |
| P/E Ratio | ★ $34.78 | $163.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.23 | $169.63 |
| 52 Week High | $108.49 | $525.51 |
| Indicator | HALO | HUBS |
|---|---|---|
| Relative Strength Index (RSI) | 77.65 | 56.70 |
| Support Level | $67.12 | $181.78 |
| Resistance Level | N/A | $258.00 |
| Average True Range (ATR) | 3.53 | 14.98 |
| MACD | 0.75 | 1.13 |
| Stochastic Oscillator | 97.08 | 79.55 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.